Paper20176910
CEM-101 activity against Gram-positive organisms.
Woosley LN and 2 others. Antimicrob Agents Chemother, 2010. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. CEM-101 activity against Gram-positive organisms. Papers, record 20176910. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20176910
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Gram-Positive Bacteria | Major topic |
| Macrolides | Major topic |
| Triazoles | Major topic |
| Azithromycin | |
| Ceftriaxone | |
| Clarithromycin | |
| Drug Synergism | |
| Erythromycin | |
| Gentamicins | |
| Ketolides | |
| Microbial Sensitivity Tests | |
| Ofloxacin | |
| Staphylococcus aureus | |
| Staphylococcus epidermidis | |
| Streptococcus pneumoniae | |
| Streptococcus pyogenes | |
| Trimethoprim, Sulfamethoxazole Drug Combination | |
| Vancomycin |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15811021 | Current and emerging serious Gram-positive infections. | Clin Microbiol Infect | 2005 | https://conductscience.org/library/papers/15811021 | PubMed |
| 2 | 19085949 | Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases. | Hepatology | 2009 | https://conductscience.org/library/papers/19085949 | PubMed |
| 3 | 11324679 | Review of macrolides and ketolides: focus on respiratory tract infections. | Drugs | 2001 | https://conductscience.org/library/papers/11324679 | PubMed |
| 4 | 19151038 | In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS). | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19151038 | PubMed |
| 5 | 15980400 | Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15980400 | PubMed |
| 6 | 11120939 | Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11120939 | PubMed |
| 7 | 14519674 | Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/14519674 | PubMed |
| 8 | 19164155 | Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19164155 | PubMed |
| 9 | 15504828 | Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15504828 | PubMed |
| 10 | 15056640 | Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. | J Antimicrob Chemother | 2004 | https://conductscience.org/library/papers/15056640 | PubMed |
| 11 | 12149046 | The ketolides: a critical review. | Drugs | 2002 | https://conductscience.org/library/papers/12149046 | PubMed |
| 12 | 19258276 | Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19258276 | PubMed |
| 13 | 11062201 | Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan. | J Antimicrob Chemother | 2000 | https://conductscience.org/library/papers/11062201 | PubMed |
| 14 | 15109426 | Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. | Emerg Infect Dis | 2004 | https://conductscience.org/library/papers/15109426 | PubMed |
| 15 | 16545937 | Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. | Diagn Microbiol Infect Dis | 2006 | https://conductscience.org/library/papers/16545937 | PubMed |
| 16 | 16723563 | DNA microarray for detection of macrolide resistance genes. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16723563 | PubMed |
| 17 | 12951334 | Induction of telithromycin resistance in Streptococcus pneumoniae. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/12951334 | PubMed |
| 18 | 20211548 | Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. | Int J Antimicrob Agents | 2010 | https://conductscience.org/library/papers/20211548 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938734 | Clinical Development of Antibacterial Drugs: Recent Progress and Future Outlook. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938734 | PubMed |
| 40868007 | The Current Landscape of Antibiotic Use and Antimicrobial Resistance in Japan: Focusing on Common Infections Including Uncomplicated Urinary Tract Infection and Gonorrhea. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40868007 | PubMed |
| 35745018 | Dinuclear vs. Mononuclear Copper(II) Coordination Species of Tylosin and Tilmicosin in Non-Aqueous Solutions. | Molecules | 2022 | https://conductscience.org/library/papers/35745018 | PubMed |
| 31932436 | A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31932436 | PubMed |
| 30054232 | How Macrolide Antibiotics Work. | Trends Biochem Sci | 2018 | https://conductscience.org/library/papers/30054232 | PubMed |
| 29891609 | Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29891609 | PubMed |
| 29608052 | Modern Approaches for Asymmetric Construction of Carbon-Fluorine Quaternary Stereogenic Centers: Synthetic Challenges and Pharmaceutical Needs. | Chem Rev | 2018 | https://conductscience.org/library/papers/29608052 | PubMed |
| 29229833 | Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29229833 | PubMed |
| 28664582 | The macrolide antibiotic renaissance. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/28664582 | PubMed |
| 27909995 | Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. | Drugs | 2016 | https://conductscience.org/library/papers/27909995 | PubMed |
| 27044551 | Results from the Solithromycin International Surveillance Program (2014). | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27044551 | PubMed |
| 24900314 | Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity. | ACS Med Chem Lett | 2011 | https://conductscience.org/library/papers/24900314 | PubMed |
| 24379197 | In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24379197 | PubMed |
| 24277019 | Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24277019 | PubMed |
| 24189250 | Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24189250 | PubMed |
| 23318809 | Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23318809 | PubMed |
| 22802254 | Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22802254 | PubMed |
| 22354296 | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22354296 | PubMed |
| 21282444 | Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21282444 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20176910
GET https://conductscience.org/api/papers/v1/20176910/authors